In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Accuray completes $174mm IPO

Executive Summary

Accuray (radiosurgery system for cancer) netted $174mm through its initial public offering of 10.4mm common shares (including the overallotment) at $18 each. The company had originally planned to offer 7.33mm shares priced between $14-16. Selling stockholders also issued 8mm shares.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies